Flow responsive endothelial Pnpt1: an exoribonuclease that regulates mitochondrial function and vascular disease
流量响应内皮 Pnpt1:一种调节线粒体功能和血管疾病的核糖核酸外切酶
基本信息
- 批准号:9750410
- 负责人:
- 金额:$ 5.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-01 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:5&apos-exoribonucleaseAneurysmApolipoprotein EApoptoticAtherosclerosisAutophagocytosisBioinformaticsBiological AssayBlood VesselsCRISPR/Cas technologyCardiovascular DiseasesCarotid EndarterectomyCell CycleCell LineCell physiologyCellsCellular Metabolic ProcessChromosomes, Human, Pair 11Congenic MiceDNA biosynthesisDataData AnalysesDrug DesignEncyclopediasEndothelial CellsEnzymesEventExhibitsExoribonucleasesFibroblastsFunctional disorderGene ExpressionGenerationsGenesGenetic PolymorphismGenetic TranscriptionGenomeGoalsGrowthHomeostasisHumanHypertensionIn VitroInflammationInflammatoryKnockout MiceLesionLigationLinkMeasuresMediatingMediator of activation proteinMetabolicMetabolic PathwayMetabolismMitochondriaMitochondrial RNAModelingMolecularMorphologyMouse StrainsMusOxidative StressPathogenesisPathologic ProcessesPathologyPathway AnalysisPathway interactionsPatternPhosphorylationPhosphorylation SitePolyribonucleotide NucleotidyltransferaseProcessProductionProtein Binding DomainProteinsProtocols documentationQuantitative Trait LociRNA DegradationRNA ProcessingRoleSignal TransductionSiteSmooth Muscle MyocytesSolidSpecimenStressTimeTranscriptTranscription Factor 3Transgenic MiceTunica IntimaVascular DiseasesVascular Smooth MuscleVascular remodelingbasecardiovascular risk factorcell growthdifferential expressionenzyme activityexperimental studyimprovedin vivointima mediamitochondrial dysfunctionmouse modelmutantnew therapeutic targetnovelprogramstherapeutic targettranscription factortranscriptome sequencingtranscriptomicsvascular inflammationvascular smooth muscle cell proliferation
项目摘要
This proposal aims to delineate molecular mechanisms that link laminar flow mediated signaling with gene
expression, mitochondrial homeostasis and endothelial cell (EC) function. Carotid intima-media thickening
(IMT) is caused by intima growth, and is a significant risk factor for cardiovascular diseases (CVD). Intima
growth is mediated by EC dysfunction, vascular smooth muscle cell (VSMC) growth as well as inflammatory
cell accumulation and activation. These pathological processes are stimulated by a disturbed flow pattern (d-
flow), while being minimized by steady s-flow. Using congenic mouse strains, we identified a QTL for intima in
C3H/F (no intima) and SJL (high intima) mice on chromosome 11 (Im2) that overlapped with a vascular
inflammation QTL. Transcriptomic and bioinformatic analyses revealed significant differences in inflammation,
cell cycle and RNA degradation. Using KEGG pathway analysis, a focus on genes in Im2 with polymorphisms
that were differentially expressed between C3H/F and SJL identified a single gene: polyribonucleotide
nucleotidyltransferase 1 (Pnpt1), a 3'-5' exoribonuclease that is required for import and processing of RNA in
mitochondria. High level Pnpt1 expression correlated with decreased intima growth and inflammation in the
carotid ligation model suggesting it was protective. The goal of this proposal is to understand how Pnpt1
restricts inflammation and atherosclerosis, focusing on novel transcriptional programs and mechanisms that
link d-flow-mediated signaling through mitochondrial homeostasis, mitophagy/autophagy and cellular RNA
processing pathways to EC dysfunction and CVD. While intima growth is primarily due to proliferation of VSMC
and fibroblast-like cells, we focused on d-flow-mediated effects on EC because we believe these signals are
initiating events, and are likely more specific and better therapeutic targets. We hypothesize that Pnpt1 is a
mechanoresponsive enzyme that is critical to mitochondrial homeostasis and acts as a negative regulator of
vascular inflammation and intima growth, thereby limiting CVD. Exciting preliminary data in support of the
hypothesis include 1) inducible EC-specific Cre-loxP Pnpt1 mice that exhibit increased intima formation upon
loss of Pnpt1; 2) RNA-Seq analyses of altered Pnpt1 expression under different flow patterns identified a novel
and significant role for the TFAP2b/c transcription factor; 3) d-flow inhibited Pnpt1 function in EC; 4) Pnpt1
expression regulated EC inflammatory and apoptotic signaling both in vivo and in vitro and 5) Pnpt1 deficiency
exacerbated mitochondrial-stress, as measured by ROS generation and autophagy. Proposed experiments will
study changes in vascular remodeling and atherosclerosis in transgenic mouse models; determine the
transcriptional program regulated by Pnpt1 focusing on the TFAP2b/c transcription factor; and the mechanisms
by which flow regulates Pnpt1 function assayed by expression and enzyme activity. This proposal will
characterize for the first time the role of Pnpt1, a major enzyme for mitochondrial RNA import and processing,
in mouse models of atherosclerosis and vascular remodeling and in human carotid endarterectomy specimens.
该建议旨在描述将层流介导的信号与基因联系起来的分子机制
表达,线粒体稳态和内皮细胞(EC)功能。颈动脉内膜媒体增厚
(IMT)是由内膜增长引起的,是心血管疾病(CVD)的重要危险因素。 intima
EC功能障碍,血管平滑肌细胞(VSMC)生长以及炎症介导
细胞积累和激活。这些病理过程受到干扰流动模式的刺激(d-
流动),同时被稳定的S-Flow最小化。使用先天小鼠菌株,我们确定了Intima的QTL
C3H/F(无内膜)和SJL(高内膜)小鼠在11(IM2)上与血管重叠
炎症QTL。转录组和生物信息学分析显示,炎症有显着差异,
细胞周期和RNA降解。使用KEGG途径分析,重点是具有多态性的IM2基因
在C3H/F和SJL之间差异表达的单个基因:polyribibonucleotide
核苷酸转移酶1(PNPT1),一种3'-5'驱核核酸酶,在进口和加工RNA中需要
线粒体。高水平的PNPT1表达与内膜生长的降低和炎症相关
颈动脉连接模型表明它具有保护性。该提议的目的是了解PNPT1如何
限制炎症和动脉粥样硬化,重点是新的转录程序和机制
通过线粒体稳态,线粒体/自噬和细胞RNA链接D-Flow介导的信号传导
处理EC功能障碍和CVD的处理途径。虽然Intima的生长主要是由于VSMC的增殖
和成纤维细胞样细胞,我们专注于D-Flow介导的对EC的影响,因为我们认为这些信号是
发起事件,可能是更具体,更好的治疗靶标。我们假设PNPT1是
机械响应酶对线粒体稳态至关重要,并且是负调节剂
血管炎症和内膜生长,从而限制CVD。令人兴奋的初步数据支持
假设包括1)可诱导的EC特异性CRE-loxp PNPT1小鼠,其内膜形成增加
损失PNPT1; 2)在不同流动模式下改变PNPT1表达的RNA-seq分析确定了一种新型
TFAP2B/C转录因子的重要作用; 3)D-Flow抑制EC中的PNPT1功能; 4)PNPT1
表达调节EC的EC炎症和凋亡信号在体内和体外均和5)PNPT1缺乏症
通过ROS的产生和自噬来测量的线粒体压力加剧。建议的实验将
研究转基因小鼠模型中血管重塑和动脉粥样硬化的研究变化;确定
由PNPT1调节的转录程序重点是TFAP2B/C转录因子;和机制
通过表达和酶活性测定的流动调节PNPT1功能。该提议将
首次表征PNPT1的作用,PNPT1是线粒体RNA进口和加工的主要酶,
在动脉粥样硬化和血管重塑的小鼠模型中以及人颈动脉内膜切除术标本中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bradford C Berk其他文献
841-6 Interleukin-18 and interleukin-18 binding protein in patients with acute coronary syndromes
- DOI:
10.1016/s0735-1097(04)92143-2 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Craig R Narins;David A Lin;Zheng-Gen Jin;Bradford C Berk - 通讯作者:
Bradford C Berk
Bradford C Berk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bradford C Berk', 18)}}的其他基金
PDE10A Regulation and Function in Cardiovascular Disease
PDE10A 在心血管疾病中的调节和功能
- 批准号:
9888405 - 财政年份:2017
- 资助金额:
$ 5.3万 - 项目类别:
Flow Responsive Mediators of Inflammation and Survival
炎症和生存的流量响应介质
- 批准号:
8024878 - 财政年份:2011
- 资助金额:
$ 5.3万 - 项目类别:
Flow Responsive Mediators of Inflammation and Survival
炎症和生存的流量响应介质
- 批准号:
8208041 - 财政年份:2011
- 资助金额:
$ 5.3万 - 项目类别:
Flow Responsive Mediators of Inflammation and Survival
炎症和生存的流量响应介质
- 批准号:
8588987 - 财政年份:2011
- 资助金额:
$ 5.3万 - 项目类别:
Flow Responsive Mediators of Inflammation and Survival
炎症和生存的流量响应介质
- 批准号:
8434911 - 财政年份:2011
- 资助金额:
$ 5.3万 - 项目类别:
2007 Vascular Cell Biology Gordon Research Conference
2007年血管细胞生物学戈登研究会议
- 批准号:
7273048 - 财政年份:2006
- 资助金额:
$ 5.3万 - 项目类别:
相似国自然基金
核糖核酸酶DIS3调控小鼠精子发生与雄性生育力的分子机制研究
- 批准号:32370904
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于点击化学的核糖核酸酶靶向嵌合体优化研究
- 批准号:82373784
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
前列腺癌人胰核糖核酸酶4表达相关的化学交换饱和转移磁共振成像定量分析研究及其机制探索
- 批准号:82371932
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
核糖核酸酶抑制因子在炎症性肠病中的调控机制及意义
- 批准号:82370550
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
核糖核酸酶复合物蛋白亚基RPP25调控CD276介导乳腺癌免疫逃逸的功能和机制研究
- 批准号:82203627
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
XRN2-DDX23 Cooperation in Avoiding R-loop-induced Genomic Instability
XRN2-DDX23 合作避免 R 环引起的基因组不稳定
- 批准号:
10654331 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Mechanistic insights into multifaceted roles of coronavirus exoribonuclease complex
冠状病毒外核糖核酸酶复合物多方面作用的机制见解
- 批准号:
10713523 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Novel Triple-Negative Breast cancer vulnerability governed by PNPT1-mediated RNA decay
由 PNPT1 介导的 RNA 衰变控制的新型三阴性乳腺癌脆弱性
- 批准号:
10606114 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Mechanisms of viral RNA maturation by co-opting cellular exonucleases
通过选择细胞核酸外切酶使病毒 RNA 成熟的机制
- 批准号:
10814079 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Investigating the connection between aberrant R-loop formation and genome instability
研究异常 R 环形成与基因组不稳定性之间的联系
- 批准号:
10750839 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别: